Silenced NEDD4L facilitated ESCC cell proliferation, migration and invasion and inhibited apoptosis in vitro, and accelerated tumour growth in vivo, while KLF5 inhibition produced an opposite effect. Here, NEDD4L is linked to esophageal squamous cell carcinoma.